Brain-injured Patients Extubation Readiness Study
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Sep 4, 2019
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Brain-injured Patients Extubation Readiness Study, or BIPER, is a clinical trial designed to help critically-ill patients with brain injuries who need to be taken off mechanical ventilation, which is a machine that helps them breathe. The study looks at using a simple scoring system to determine if these patients are ready to have their breathing tube removed, aiming to reduce the chances of complications after extubation, or the process of removing the tube.
To be eligible for this study, participants should be between 18 and 75 years old and have a recent brain injury that requires them to be in the intensive care unit (ICU) on a ventilator for more than 48 hours. They should also show some signs of stability, like being able to breathe on their own during certain tests. If someone meets these criteria and chooses to participate, they can expect to be part of a process that may help improve care for future patients with similar conditions. It's important to know that not everyone will qualify, as there are specific health conditions that could exclude them from the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Acute cerebral lesion with a Glasgow Coma Scale \< 13 needing admission in ICU and mechanical ventilation with tracheal intubation for neurological cause : cerebrovascular stroke either ischemic or hemorrhagic including aneurysmal subarachnoid hemorrhage, traumatic brain injury or anoxo ischemic encephalopathy after cardiac arrest
- • Mechanical ventilation more than 48 hours
- • 18 to 75 years old
- • Neurological stability with no intracranial hypertension with minimal sedation
- • Glasgow Coma Scale motor response \< 6
- • Spontaneous breathing trial succeeded
- • First extubation attempt
- Exclusion Criteria:
- • Posterior cranial fossa lesion
- • Admission for status epilepticus or central nervous system infection
- • Spinal cord injury (tetraplegia or paraplegia)
- • Uncontrolled status epilepticus or uncontrolled central nervous system infection
- • Life expectancy less than 48 hours or withdrawal of life sustaining therapy
- • Chronic respiratory failure
- • More than 3 failed spontaneous breathing trials
- • Chest trauma (more than 2 broken ribs / broken sternum / with an indication of open thoracic surgery)
- • Surgery planned within 7 days
- • Tracheotomy
- • Previous compromised upper airway permeability
- • Pregnant or breastfeeding woman
- • Adult under the protection of the law or without social assurance system
- • Inclusion in another clinical study about ventilation weaning
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Angers, , France
Bordeaux, , France
Grenoble, , France
Toulouse, , France
Lille, , France
Clermont Ferrand, , France
Poitiers, , France
Lyon, , France
Nîmes, , France
Montpellier, , France
Valence, , France
Saint Etienne, , France
Caen, , France
Rennes, , France
Paris, , France
Nantes, , France
Marseille, , France
Bourg En Bresse, , France
Nice, , France
La Réunion, , France
Patients applied
Trial Officials
Russell Chabanne
Study Director
University Hospital, Clermont-Ferrand
Olivier Vincent
Principal Investigator
University Hospital, Grenoble
Florent Gobert
Principal Investigator
Hospices Civils de Lyon
Jérôme Morel
Principal Investigator
CHU SAINT-ETIENNE
Matthieu Jeannot
Principal Investigator
CH VALENCE
Pierre-André Rodié-Talbère
Principal Investigator
Nantes University Hospital
Thomas Geeraerts
Principal Investigator
CHU Toulouse
Pierre-François Perrigault
Principal Investigator
University Hospital, Montpellier
Claire Roger
Principal Investigator
CHU Nîmes
Carole Ichai
Principal Investigator
CHU NICE
Mohamed Khemili
Principal Investigator
Fondation Ophtalmologique Adolphe de Rothschild
Camille Bouisse
Principal Investigator
CH de Bourg-en-Bresse
Natalie De Sa
Principal Investigator
CHU Lille
Sigismond Lasocki
Principal Investigator
University Hospital, Angers
Claire Dahyot-Fizelier
Principal Investigator
CHU Poitiers
Yoann Launey
Principal Investigator
CHU Rennes
Laurent Petit
Principal Investigator
CHU Bordeaux - Réanimation Chirurgicale et traumatologique
Hugues De Courson
Principal Investigator
CHU Bordeaux - Réanimation Neurologique
Clément Gakuba
Principal Investigator
CHU Caen Normandie
Sophie Kauffmann
Principal Investigator
CHU de La Réunion
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials